tiprankstipranks
Kissei Pharmaceutical Co Ltd (KSPHF)
OTHER OTC:KSPHF
US Market
KSPHF
Kissei Pharmaceutical Co
RESEARCH TOOLSreports
Want to see KSPHF full AI Analyst Report?

Kissei Pharmaceutical Co (KSPHF) Financial Statements

11 Followers

Kissei Pharmaceutical Co Financial Overview

Kissei Pharmaceutical Co's market cap is currently $1.13B. The company's EPS TTM is $; its P/E ratio is 14.92; and it has a dividend yield of 2.74%. Kissei Pharmaceutical Co is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 88.33B¥ 75.58B¥ 67.49B¥ 65.38B¥ 69.04B
Gross Profit¥ 44.06B¥ 37.34B¥ 32.38B¥ 31.24B¥ 32.72B
Operating Income¥ 5.77B¥ 4.02B¥ -1.13B¥ -1.40B¥ 1.50B
EBITDA¥ 20.25B¥ 18.72B¥ 17.81B¥ 20.26B¥ 10.65B
Net Income¥ 11.96B¥ 11.16B¥ 10.53B¥ 12.92B¥ 5.29B
Balance Sheet
Cash & Short-Term Investments¥ 48.65B¥ 45.93B¥ 49.60B¥ 53.15B¥ 44.45B
Total Assets¥ 244.06B¥ 260.93B¥ 221.20B¥ 238.09B¥ 268.86B
Total Debt¥ 1.60B¥ 1.73B¥ 1.95B¥ 1.98B¥ 2.18B
Net Debt¥ -23.57B¥ -21.17B¥ -23.94B¥ -28.03B¥ -18.28B
Total Liabilities¥ 33.93B¥ 39.79B¥ 26.38B¥ 35.91B¥ 48.90B
Stockholders' Equity¥ 209.00B¥ 220.03B¥ 193.90B¥ 201.39B¥ 219.31B
Cash Flow
Free Cash Flow¥ 2.01B¥ -2.88B¥ -8.78B¥ 44.00M¥ -3.47B
Operating Cash Flow¥ 6.52B¥ -1.68B¥ -6.68B¥ 1.53B¥ -2.54B
Investing Cash Flow¥ 4.95B¥ 8.69B¥ 6.00B¥ 10.78B¥ -9.33B
Financing Cash Flow¥ -9.32B¥ -10.01B¥ -3.42B¥ -2.76B¥ -4.00B
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History

Income Statement >

Kissei Pharmaceutical Co Debt to Assets

Balance Sheet >

Kissei Pharmaceutical Co Cash Flow

Cash Flow >

Kissei Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >